Anti-KSA cancer vaccine (IDM Pharma)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAnti-KSA cancer vaccine (IDM Pharma)
Drug Alias NameProstate cancer vaccine-IDM
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulantsEpithelial cell adhesion molecule inhibitors
TargetsEpithelial cell adhesion molecule
Therapy Area/IndicationsProstatic NeoplasmsColorectal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesIdm Pharma
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsProstatic NeoplasmsColorectal Neoplasms

Other Information

ATC CodeN/A
Related LinksWikipedia